Company intelligence / Profile preview
Birzeit Pharmaceutical Company
- Ownership
- Private
- Employees
- ~170
- Development stage
- Other
Overview
Birzeit Pharmaceutical Company manufactures and distributes over 270–300 pharmaceutical products, primarily generics, across a wide range of therapeutic areas, with the majority of products already commercialized in Palestine and export markets
- Therapeutic areas
- Metabolic DisordersOphthalmologyInfectious DiseasesGastroenterologyPulmonologyDermatologyCardiovascularOtherNeurology
- Modalities
- Small moleculeBiologicProtein
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Birzeit Pharmaceutical Company.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Birzeit Pharmaceutical Company.